Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer
Open Access
- 14 October 2023
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 21 (1) , 1-18
Abstract
Background: Triple-negative breast cancer (TNBC) development may be associated with tumor immune escape. This study explores whether the CHI3L1/MAF/CTLA4/S100A4 axis affects immune escape in TNBC through interplay with triple-negative breast cancer stem cells (TN-BCSCs). Objective: The aim of this study is to utilize single-cell transcriptome sequencing (scRNA-seq) to uncover the molecular mechanisms by which the CHI3L1/MAF/CTLA4 signaling pathway may mediate immune evasion in triple-negative breast cancer through the interaction between tumor stem cells (CSCs) and immune cells. Methods: Cell subsets in TNBC tissues were obtained through scRNA-seq, followed by screening differentially expressed genes in TN-BCSCs and B.C.s (CD44+ and CD24−) and predicting the transcription factor regulated by CHI3L1. Effect of CHI3L1 on the stemness phenotype of TNBC cells investigated. Effects of BCSCs-231-derived CHI3L1 on CTLA4 expression in T cells were explored after co-culture of BCSCs-231 cells obtained from microsphere culture of TN-BCSCs with T cells. BCSCs-231-treated T cells were co-cultured with CD8+ T cells to explore the resultant effect on T cell cytotoxicity. An orthotopic B.C. transplanted tumor model in mice with humanized immune systems was constructed, in which the Role of CHI3L1/MAF/CTLA4 in the immune escape of TNBC was explored. Results: Eight cell subsets were found in the TNBC tissues, and the existence of TN-BCSCs was observed in the epithelial cell subset. CHI3L1 was related to the stemness phenotype of TNBC cells. TN-BCSC-derived CHI3L1 increased CTLA4 expression in T cells through MAF, inhibiting CD8+ T cell cytotoxicity and inducing immunosuppression. Furthermore, the CTLA4+ T cells might secrete S100A4 to promote the stemness phenotype of TNBC cells. Conclusions: TN-BCSC-derived CHI3L1 upregulates CTLA4 expression in T cells through MAF, suppressing the function of CD8+ T cells, which promotes the immune escape of TNBC.Keywords
Funding Information
- Guangdong Provincial Medical Science and Technology Research Fund in 2021 (A2021039)
- Natural Science Foundation of Guangdong Province in 2022 (2022A1515012183)
- National Natural Science Foundation of China in 2023 (82272968)
- The “XINRUI” Project of Cancer Supportive Care and Treatment Research in 2022 (cphcf-2022-088)
This publication has 53 references indexed in Scilit:
- Introduction to Cancer Stem Cells: Past, Present, and Future2017
- Combined immune checkpoint blockade as a therapeutic strategy for BRCA1 -mutated breast cancerScience Translational Medicine, 2017
- Characterization of c-Maf+Foxp3− Regulatory T Cells Induced by Repeated Stimulation of Antigen-Presenting B CellsScientific Reports, 2017
- The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMBScience Signaling, 2017
- Cancer stem cell metabolismBreast Cancer Research, 2016
- Functional profile of S100A4‐deficient T cellsImmunity, Inflammation and Disease, 2015
- Enhanced MAF Oncogene Expression and Breast Cancer Bone MetastasisJNCI: Journal of the National Cancer Institute, 2015
- S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balanceBMC Cancer, 2015
- limma powers differential expression analyses for RNA-sequencing and microarray studiesNucleic Acids Research, 2015
- S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migrationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010